Why React4life?
By a scientist team, who think as biologists and act as biomedical engineers, to technology to enable the researchers transforming their testing concept in concrete programs, providing an in vitro human systemic platform that allows the use of clinically-relevant size tissue models and physiological fluidic environments.
Read more about us
Reliable
Perform realistic, controlled and reproducible tests in a 3D human systemic environment.
Efficient
Save time and money, turning what you use into disposable MIVO device, which adds human and systemic benefits to your tests.
Customizable
Keep your cells and tissues, use your protocol assays, move on MIVO platform for novel testing needs.
Cruelty free
Contribute to a sustainable cruelty free future.
The biology in lab and in REAL life
Science shows that tests carried out in 2D-standard assays are too simplistic and don’t represent the complexity of real tissues. Moreover, such tests are typically executed under static conditions, although biological life is dynamic: this leads to errors and lack of outcome reliability.
From the excellence of the Italian research, a team of scientists with international collaborations has designed MIVO®, a biology driven technology that put together 3D tissues and the fluidics governing biological processes.
Testimonial
«I appreciate most from the collaboration with the React4life team is the desire to understand what our needs are and not to travel on parallel tracks but on tracks that intersects with the sharing of needs and the integration of mutual skills»
Researcher and professor at CEBR, Center of Excellence for the study of molecular mechanisms of communication between cells: from basic research to the clinicLead Editor per lo special issue “Immunotherapy in the treatment of human solid tumor: basic and translational aspect” (Journal of Immunology Research: https://www.hindawi.com/journals/jir/si/142926/cfp/)
Our clients
NEWS
-
Reducing the time and cost of screening for new compounds and limiting the number of animals used in in-vivo tests is the future of drug discovery. GalleryReducing the time and cost of screening for new compounds and limiting the number of animals used in in-vivo tests is the future of drug discovery.
Reducing the time and cost of screening for new compounds and limiting the number of animals used in in-vivo tests is the future of drug discovery.
Cristina Degrassi, CEO of MTTLab, tells us about her experience with React4life which led to the publication of the paper on Altex: "3D fluid-dynamic ovarian cancer model resembling systemic drug administration for efficacy assay". The ability to control drugs quickly and efficiently with a more accurate preclinical tumor model is of great importance in drug development, as the tests used still have severe problems and poor predictivity. Considering the limitations of animal experiments to predict human response and the high need for new drugs, it is necessary to include highly reproducible human systemic tumor models in preclinical analyzes to [...]
React4life is proudly supported by
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 827655
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 801159
